DARKPOOL0.1.0
AFT-MKT Sign in
ZBIO
Zenas BioPharma, Inc.
NMS Equity
28.70
+0.12 (+0.42%)
52w low 13.50 44.60 high
48.9% of range

Financial Analysis

Quarterly
(USD) Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26 Trend
Operating Cash Flow -----41.12M-52.41M-75.20M-57.24M-57.98M
Depreciation & Amort ----11.00K10.00K6.00K4.00K4.00K
Capital Expenditure -18.00K---5.00M-30.00M-2.00K-30.00M--
Free Cash Flow -----46.12M-82.41M-75.20M-87.24M-27.98M
Investing Cash Flow ----40.04M-93.36M31.61M-287.70M-19.21M
Financing Cash Flow ----72.62M140.84M433.48M42.06M57.21M
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+900.0%